8th MSL Best Practices

As the healthcare landscape in the United States continues to change, the role of the medical science liaison (MSL) is growing in relevance and importance. Stricter regulations, increased competition, and shrinking pipelines are contributing to higher stakes and the need for pharmaceutical, biotech and medical device companies to have highly effective MSL teams in place. The education and product awareness that MSLs bring to thought leaders and the broader medical community are essential to corporate sustainability and success. Further, the peer-to-peer relationships that MSL initiate and maintain with KOLs and the field insights that are honed and brought back to the company are fundamental, particularly as sales forces are being reduced throughout the nation. The strong business acumen, communication skills, and therapeutic area expertise that MSLs possess are tools that are tremendously meaningful, and when channeled properly, can be enormously valuable to both internal and external stakeholders.

Building from the success of seven previous events, ExL Pharma’s 8th MSL Best Practices is designed to provide attendees with information on the latest trends, changes, and best practices for MSLs operating in such a complex environment. Attending this event provides exciting opportunities for networking with industry colleagues and benchmarking activities, strategies and goals. The expert speaking faculty and highly informed topics help MSLs effectively meet the needs of internal and external customers, while remaining professionally fulfilled.

We look forward to greeting you in April!

Testimonials

“I was really impressed with virtually everything about this event. The topics were right on target, the speakers were great, having lots of time for questions and interactive discussions was perfect.” – Medical Scientific Manager, Allergan

“Exceeded my expectations” - MSL, Tercica

“Excellent seminar…will attend in the future” – MSL, Millennium

“Very well run and designed” – National Clinical Science Manager, Abbott

Top Five Reasons to Attend

1. The Networking:  The MSL Best Practices event is tri-located with ExL’s Medical Affairs Executive Forum and the 13th Investigator-Initiated Trials Conference!  Triple your networking opportunities and discuss common challenges and solutions during shared breaks, lunches, roundtable discussions and cocktail reception.

2. The Topics:  Gain concrete strategies that are relevant to your daily jobs, including:  MSL team metrics, operating in an increasingly complex regulatory environment, increasing compliant collaboration with commercial teams, understanding the needs of KOLs, and much, much more!

3. The Speakers:  Hear from senior level executives with unmatched experience from the following companies:  Amgen, Bayer Healthcare, Boehringer Ingelheim, Shire, Eli Lilly & Co., Celgene, Actelion Pharmaceuticals, US, Genzyme, Eisai, Shire, Ikaria, and others.

4. The Workshops:  Choose from two different workshops led by industry experts, depending on your interests and relevant experience. 

5. The History:  ExL Pharma’s MSL Best Practices is now running for the eighth time in the US, and now has proven success in Europe as well.  ExL prides itself on offering cutting edge information, through highly researched and targeted topics that continue to meet the educational needs of medical affairs executives throughout the industry. 

JUSTIFY YOUR TRIP!
If you have to first convince your boss it’s worth your time and the company’s money to go, you’re not alone. Past conference attendees have helped us create justification documents that will let you make your case on why this is a must attend conference for you. Feel free to download and customize the letters below as you see fit, adding immediate problems you’ll be able to solve and long-term initiatives you’ll be able to implement. Chances are good you’ll be able to do those things… and more after the conclusion of our 2011 event. 

• CLICK HERE TO DOWNLOAD OUR JUSTIFICATION PROPOSAL